Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asenapine in acute manic or mixed episodes of Bipolar 1 Disorder
NCT00764478Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Apr 2012
- Primary completion
- Apr 2014
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of asenapine in bipolar I disorder, sponsored by Organon & Co.. Started Apr 2012; status: completed.
02
Drugs
asenapine
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00764478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764478.